| Julia A Carter, MD | |
|
700 Neapolitan Way, Naples, FL 34103-8570 | |
| (239) 261-8383 | |
| (239) 261-8443 |
| Full Name | Julia A Carter |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 700 Neapolitan Way, Naples, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164692935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME100389 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Sight Pl | 1658340294 | 51 |
News Archive
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Bob Wilson is not a quitter, and the Parkinson's Center of Oregon at Oregon Health & Science University will benefit from his steely determination October 10 when he and other members of "Team Bob" mount specially constructed bicycles for a fund-raising outing at The Springs at Tanasbourne.
Yesterday, the Medical Device Manufacturers Association Board of Directors met and unanimously voted to oppose any device tax as part of the health care reform bills moving through Congress.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
› Verified 6 days ago
| Entity Name | Center For Sight Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386718468 PECOS PAC ID: 1658340294 Enrollment ID: O20040929001217 |
News Archive
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Bob Wilson is not a quitter, and the Parkinson's Center of Oregon at Oregon Health & Science University will benefit from his steely determination October 10 when he and other members of "Team Bob" mount specially constructed bicycles for a fund-raising outing at The Springs at Tanasbourne.
Yesterday, the Medical Device Manufacturers Association Board of Directors met and unanimously voted to oppose any device tax as part of the health care reform bills moving through Congress.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julia A Carter, MD 1360 E Venice Ave, Venice, FL 34285-9066 Ph: (941) 480-2135 | Julia A Carter, MD 700 Neapolitan Way, Naples, FL 34103-8570 Ph: (239) 261-8383 |
News Archive
A study by Helmholtz Zentrum München concludes that during the second Corona wave, three to four times more children in Bavaria, Germany were infected with the Corona virus than reported via PCR tests.
Bob Wilson is not a quitter, and the Parkinson's Center of Oregon at Oregon Health & Science University will benefit from his steely determination October 10 when he and other members of "Team Bob" mount specially constructed bicycles for a fund-raising outing at The Springs at Tanasbourne.
Yesterday, the Medical Device Manufacturers Association Board of Directors met and unanimously voted to oppose any device tax as part of the health care reform bills moving through Congress.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
› Verified 6 days ago
Victoria Chang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3880 Tamiami Trl N, Naples, FL 34103 Phone: 239-659-3944 | |
Dr. James Sheridan Kelley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2355 Stanford Ct Unit 701, Naples, FL 34112 Phone: 239-566-7425 Fax: 239-593-3430 | |
Dr. Howard Lee Freedman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2171 Pine Ridge Rd, Suite F, Naples, FL 34109 Phone: 239-566-7425 Fax: 239-593-3430 | |
Dr. Lynn Kepple Byerly, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 661 Goodlette Rd N, Suite 105, Naples, FL 34102 Phone: 239-262-6288 Fax: 239-262-5434 | |
Dr. George Briton Fisher Iii, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 875 105th Ave North, Naples, FL 34108 Phone: 239-431-7070 Fax: 239-431-7075 | |
Dr. Jon R Berlie, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 700 Neapolitan Way, Naples, FL 34103 Phone: 239-261-8383 Fax: 239-261-8443 |